Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Partners With AIM Laboratories on Cancer Tests

NEW YORK (GenomeWeb) – GeneNews announced today that it signed an agreement with reference lab AIM Laboratories under which each company will make its tests available to the other's customer base.

Specific terms of the deal were not disclosed.

GeneNews offers a line of tests for early cancer risk stratification and diagnosis through its Innovative Diagnostic Laboratory subsidiary — headquartered in Richmond, Virginia — including the blood-based test ColonSentry for colorectal cancer. St. Louis-based AIM provides a range of lab services such as routine blood testing and therapeutic drug monitoring to healthcare and corporate organizations.

"Combining forces and capitalizing on each company's geographic strengths will help both parties expand rapidly throughout the US," GeneNews Chairman and CEO James Howard-Tripp said in a statement. "In addition, this collaboration will give both companies the opportunity to expand their test menus in order to provide additional benefits to new and existing practices and healthcare systems."

Earlier this week, GeneNews reported its first quarter financial results, posting a sharp drop in revenues due to changes in its billing process.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.